Anemocyte is excited to announce its participation as an attendee at TIDES USA 2025, taking place from May 19–22, 2025, at the Manchester Grand Hyattin San Diego, California. TIDES USA is North America’s premier event dedicated to advancing oligonucleotide and peptide therapeutics, bringing together industry leaders to explore innovations in oligonucleotides, peptides, mRNA, genome editing, and drug delivery.
Key Highlights of TIDES USA 2025: cutting edge strategies and technologies
- Comprehensive Agenda: over 200 presentations across six concurrent tracks, covering the entire spectrum from discovery to commercialization.
- Expert Speakers: insights from leading scientists and industry pioneers on cutting-edge strategies and technologies.
- Networking Opportunities: engage with professionals across disciplines to foster collaborations and accelerate therapeutic development.
Anemocyte looks forward to engaging with fellow attendees to discuss advancements in manufacturing solutions that support the development of innovative therapeutics.
For more information about TIDES USA 2025, please visit the official TIDES USA website.
